Biomea Fusion, Inc.(BMEA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BMEA Biomea Fusion, Inc.

交易中 01-12 12:37:17 EST

1.48

+0.06

+4.23%

最高1.55	最低1.43	成交量196.59万
今开1.45	昨收1.42	日振幅8.45%
总市值1.05亿	流通市值8,471万	总股本7,070万
成交额295.87万	换手率3.43%	流通股本5,724万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BMEA","market":"US","secType":"STK","nameCN":"Biomea Fusion, Inc.","latestPrice":1.48,"timestamp":1768239420488,"preClose":1.42,"halted":0,"volume":1965868,"delay":0,"floatShares":57237400,"shares":70703639,"eps":-2.204976,"marketStatus":"交易中","change":0.06,"latestTime":"01-12 12:37:17 EST","open":1.45,"high":1.55,"low":1.43,"amount":2958677.9310716,"amplitude":0.084507,"askPrice":1.49,"askSize":800,"bidPrice":1.48,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-2.204976,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768251600000},"marketStatusCode":2,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":1.42,"preHourTrading":{"tag":"盘前","latestPrice":1.48,"preClose":1.42,"latestTime":"09:27 EST","volume":28356,"amount":41621.135292,"timestamp":1768228070053},"postHourTrading":{"tag":"盘后","latestPrice":1.44,"preClose":1.42,"latestTime":"19:18 EST","volume":18696,"amount":26942.8085,"timestamp":1768004284234},"volumeRatio":4.387048,"impliedVol":2.0036,"impliedVolPercentile":0.9363},"requestUrl":"/m/hq/s/BMEA","defaultTab":"news","newsList":[{"id":"2601574332","title":"Biomea Fusion, Inc.盘中异动 股价大涨5.56%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601574332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601574332?lang=zh_cn&edition=full","pubTime":"2026-01-08 00:42","pubTimestamp":1767804175,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日00时42分，Biomea Fusion, Inc.股票出现波动，股价大幅上涨5.56%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为2.08%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床阶段的糖尿病和肥胖症药物公司，专注于发现和开发用于治疗代谢疾病患者的口服共价小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108004256953c2ac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108004256953c2ac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BMEA","BK4539"],"gpt_icon":0},{"id":"1142313679","title":"Biomea Fusion在第23届世界胰岛素抵抗、糖尿病与心血管疾病大会上展示Covalent-111研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1142313679","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142313679?lang=zh_cn&edition=full","pubTime":"2025-12-05 20:07","pubTimestamp":1764936422,"startTime":"0","endTime":"0","summary":"Biomea Fusion在第23届世界胰岛素抵抗、糖尿病与心血管疾病大会上展示Covalent-111研究结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BMEA","BK4139","BK4585"],"gpt_icon":0},{"id":"1139832044","title":"Biomea Fusion宣布在第23届世界胰岛素抵抗、糖尿病与心血管疾病大会上进行Icovamenib的口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1139832044","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139832044?lang=zh_cn&edition=full","pubTime":"2025-12-02 05:11","pubTimestamp":1764623469,"startTime":"0","endTime":"0","summary":"Biomea Fusion宣布在第23届世界胰岛素抵抗、糖尿病与心血管疾病大会上进行Icovamenib的口头报告","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BK4585","BMEA"],"gpt_icon":0},{"id":"2586155152","title":"Biomea Fusion, Inc.盘中异动 下午盘股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586155152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586155152?lang=zh_cn&edition=full","pubTime":"2025-11-27 03:51","pubTimestamp":1764186683,"startTime":"0","endTime":"0","summary":"北京时间2025年11月27日03时51分，Biomea Fusion, Inc.股票出现波动，股价大幅上涨5.34%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床阶段的糖尿病和肥胖症药物公司，专注于发现和开发用于治疗代谢疾病患者的口服共价小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127035124978137cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127035124978137cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BMEA","BK4539"],"gpt_icon":0},{"id":"1137806844","title":"Biomea Fusion宣布首位患者接受Bmf-650口服GLP-1受体激动剂I期研究用药","url":"https://stock-news.laohu8.com/highlight/detail?id=1137806844","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137806844?lang=zh_cn&edition=full","pubTime":"2025-10-27 20:02","pubTimestamp":1761566559,"startTime":"0","endTime":"0","summary":"Biomea Fusion宣布首位患者接受Bmf-650口服GLP-1受体激动剂I期研究用药","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BMEA","BK4139","BK4585"],"gpt_icon":0},{"id":"1135352213","title":"Biomea Fusion Inc：Icovamenib在第52周显示糖化血红蛋白较安慰剂平均降低1.8%（B组）","url":"https://stock-news.laohu8.com/highlight/detail?id=1135352213","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135352213?lang=zh_cn&edition=full","pubTime":"2025-10-07 04:10","pubTimestamp":1759781433,"startTime":"0","endTime":"0","summary":"Biomea Fusion Inc宣布，其在研药物Icovamenib在第52周的临床试验中取得积极进展，B组患者的糖化血红蛋白(HbA1c)较安慰剂组平均降低1.8%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BMEA","BK4539"],"gpt_icon":0},{"id":"1102642939","title":"Biomea Fusion, Inc.公布2型糖尿病II期COVALENT-111研究52周积极结果，显示Icovamenib非慢性治疗对两个不同患者群体均有益处","url":"https://stock-news.laohu8.com/highlight/detail?id=1102642939","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102642939?lang=zh_cn&edition=full","pubTime":"2025-10-07 04:04","pubTimestamp":1759781054,"startTime":"0","endTime":"0","summary":"Biomea Fusion, Inc.公布2型糖尿病II期COVALENT-111研究52周积极结果，显示Icovamenib非慢性治疗对两个不同患者群体均有益处","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA","BK4139","BK4539","BK4585"],"gpt_icon":0},{"id":"2572146835","title":"Biomea Fusion, Inc.盘中异动 早盘大幅拉升5.20%报2.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572146835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572146835?lang=zh_cn&edition=full","pubTime":"2025-10-01 22:24","pubTimestamp":1759328663,"startTime":"0","endTime":"0","summary":"北京时间2025年10月01日22时24分，Biomea Fusion, Inc.股票出现异动，股价急速拉升5.20%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为2.01%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床阶段的糖尿病和肥胖症药物公司，专注于发现和开发用于治疗代谢疾病患者的口服共价小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001222423971bec68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001222423971bec68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BMEA","BK4539","BK4139"],"gpt_icon":0},{"id":"1182376766","title":"Biomea Fusion Inc的BMF-650肥胖症I期临床试验进展顺利，2026年上半年将公布28天减重数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1182376766","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182376766?lang=zh_cn&edition=full","pubTime":"2025-09-16 19:09","pubTimestamp":1758020962,"startTime":"0","endTime":"0","summary":"Biomea Fusion Inc宣布，其针对肥胖症治疗的BMF-650药物I期临床试验正按计划推进。该公司预计将在2026年上半年公布为期28天的减重效果数据，为投资者和医学界提供这一创新疗法的重要临床证据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA","BK4585","BK4139","BK4539"],"gpt_icon":0},{"id":"1109465474","title":"Biomea Fusion在第61届EASD年会上展示数据，证实Icovamenib与司马鲁肽联合治疗在2型糖尿病动物模型中显示出增强的临床前活性，并提供企业最新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1109465474","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109465474?lang=zh_cn&edition=full","pubTime":"2025-09-16 19:01","pubTimestamp":1758020491,"startTime":"0","endTime":"0","summary":"Biomea Fusion在第61届EASD年会上展示数据，证实Icovamenib与司马鲁肽联合治疗在2型糖尿病动物模型中显示出增强的临床前活性，并提供企业最新进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA","BK4585","BK4539","BK4139"],"gpt_icon":0},{"id":"2566693063","title":"Biomea Fusion, Inc.盘中异动 快速下跌5.09%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566693063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566693063?lang=zh_cn&edition=full","pubTime":"2025-09-08 23:46","pubTimestamp":1757346381,"startTime":"0","endTime":"0","summary":"北京时间2025年09月08日23时46分，Biomea Fusion, Inc.股票出现异动，股价快速下跌5.09%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床阶段的糖尿病和肥胖症药物公司，专注于发现和开发用于治疗代谢疾病患者的口服共价小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908234622a4bbb4d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908234622a4bbb4d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMEA","BK4139","BK4539","BK4585"],"gpt_icon":0},{"id":"2558007661","title":"Biomea Fusion, Inc.2025财年第二财季实现净利润-20.74百万美元，同比增加44.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558007661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558007661?lang=zh_cn&edition=full","pubTime":"2025-08-12 00:00","pubTimestamp":1754928030,"startTime":"0","endTime":"0","summary":"8月12日，Biomea Fusion, Inc.公布财报，公告显示公司2025财年第二财季净利润为-20.74百万美元，同比增加44.37%；其中营业收入为0.00美元，每股基本收益为-0.51美元。从资产负债表来看，Biomea Fusion, Inc.总负债45.65百万美元，其中短期债务755000.00美元，资产负债比为1.61，流动比率为3.69。机构评级：截至2025年8月12日，当前有6家机构对Biomea Fusion, Inc.目标价做出预测，其中目标均价为7.67美元，其中最低目标价为3.00美元，最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812000039a6dfea88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812000039a6dfea88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMEA"],"gpt_icon":0},{"id":"2558797095","title":"Biomea Fusion, Inc.盘中异动 下午盘大幅下挫5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558797095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558797095?lang=zh_cn&edition=full","pubTime":"2025-08-09 02:14","pubTimestamp":1754676885,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日02时14分，Biomea Fusion, Inc.股票出现波动，股价快速下跌5.83%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体跌幅为1.13%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床阶段的糖尿病和肥胖症药物公司，专注于发现和开发用于治疗代谢疾病患者的口服共价小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809021445a6db78cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809021445a6db78cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BMEA","BK4585","BK4139"],"gpt_icon":0},{"id":"2557856956","title":"Biomea Fusion, Inc.盘中异动 早盘急速上涨5.35%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557856956","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557856956?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:31","pubTimestamp":1754573512,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时31分，Biomea Fusion, Inc.股票出现波动，股价大幅上涨5.35%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床阶段的糖尿病和肥胖症药物公司，专注于发现和开发用于治疗代谢疾病患者的口服共价小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080721315294d59f87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080721315294d59f87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMEA","BK4139","BK4539","BK4585"],"gpt_icon":0},{"id":"2555115834","title":"Biomea Fusion, Inc.盘中异动 急速上涨5.22%报1.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555115834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555115834?lang=zh_cn&edition=full","pubTime":"2025-07-31 23:04","pubTimestamp":1753974242,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日23时04分，Biomea Fusion, Inc.股票出现波动，股价急速上涨5.22%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为2.41%。其相关个股中，Soligenix, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.涨幅较大，Soligenix, Inc.、Psyence Biomedical Ltd.、Onconetix, Inc.较为活跃，换手率分别为5758.61%、4787.75%、4581.90%，振幅较大的相关个股有Soligenix, Inc.、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为143.20%、97.88%、97.44%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床阶段的糖尿病和肥胖症药物公司，专注于发现和开发用于治疗代谢疾病患者的口服共价小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073123040294c6911c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073123040294c6911c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BMEA","BK4539"],"gpt_icon":0},{"id":"2555503780","title":"Biomea Fusion, Inc.盘中异动 早盘股价大跌5.00%报1.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555503780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555503780?lang=zh_cn&edition=full","pubTime":"2025-07-29 22:54","pubTimestamp":1753800880,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日22时54分，Biomea Fusion, Inc.股票出现波动，股价大幅跳水5.00%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床阶段的糖尿病和肥胖症药物公司，专注于发现和开发用于治疗代谢疾病患者的口服共价小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072922544194c1c6dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072922544194c1c6dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BMEA","BK4585"],"gpt_icon":0},{"id":"2551126821","title":"Biomea Fusion, Inc.盘中异动 股价大涨5.06%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551126821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551126821?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:37","pubTimestamp":1752673054,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时37分，Biomea Fusion, Inc.股票出现异动，股价急速上涨5.06%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床阶段的糖尿病和肥胖症药物公司，专注于发现和开发用于治疗代谢疾病患者的口服共价小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716213734a6ada35c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716213734a6ada35c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BMEA","BK4539","BK4139"],"gpt_icon":0},{"id":"2518331270","title":"Biomea Fusion, Inc.盘中异动 大幅跳水5.17%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518331270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518331270?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:55","pubTimestamp":1741622139,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时55分，Biomea Fusion, Inc.股票出现波动，股价急速下跌5.17%。截至发稿，该股报2.57美元/股，成交量16.4981万股，换手率0.46%，振幅7.01%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3662.66%、2664.64%、874.12%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scisparc Ltd.，振幅分别为88.14%、78.32%、49.87%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310235540a26a5a2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310235540a26a5a2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BMEA","BK4585"],"gpt_icon":0},{"id":"2517880499","title":"Biomea Fusion, Inc.盘中异动 大幅拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517880499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517880499?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:40","pubTimestamp":1741117228,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时40分，Biomea Fusion, Inc.股票出现波动，股价快速上涨5.30%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Rapport Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Protagenic Therapeutics, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为1315.96%、1231.18%、1210.94%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Plus Therapeutics, Inc.，振幅分别为122.48%、68.89%、68.09%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305034028989bf335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305034028989bf335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4585","BMEA","BK4139"],"gpt_icon":0},{"id":"2516634955","title":"Biomea Fusion, Inc.盘中异动 股价大跌5.02%报2.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634955?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:43","pubTimestamp":1741013020,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时43分，Biomea Fusion, Inc.股票出现波动，股价大幅下挫5.02%。截至发稿，该股报2.75美元/股，成交量2.8127万股，换手率0.08%，振幅6.57%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224340989a1308&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224340989a1308&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMEA","BK4139","BK4539","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biomeafusion.com","stockEarnings":[{"period":"1week","weight":0.0597},{"period":"1month","weight":-0.0779},{"period":"3month","weight":-0.1548},{"period":"6month","weight":-0.29},{"period":"1year","weight":-0.6674},{"period":"ytd","weight":0.1452}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Biomea Fusion, Inc.于2017年8月9日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于发现和开发用于治疗代谢性疾病和基因定义癌症患者的口服共价小分子药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.111607},{"month":2,"riseRate":0.25,"avgChangeRate":-0.024175},{"month":3,"riseRate":0.25,"avgChangeRate":0.175552},{"month":4,"riseRate":0,"avgChangeRate":-0.168176},{"month":5,"riseRate":0.6,"avgChangeRate":0.133765},{"month":6,"riseRate":0.4,"avgChangeRate":0.081609},{"month":7,"riseRate":0.4,"avgChangeRate":-0.019311},{"month":8,"riseRate":0.8,"avgChangeRate":0.078281},{"month":9,"riseRate":0.4,"avgChangeRate":-0.012411},{"month":10,"riseRate":0.2,"avgChangeRate":-0.126858},{"month":11,"riseRate":0.4,"avgChangeRate":-0.034764},{"month":12,"riseRate":0.4,"avgChangeRate":-0.114655}],"exchange":"NASDAQ","name":"Biomea Fusion, Inc.","nameEN":"Biomea Fusion, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biomea Fusion, Inc.(BMEA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Biomea Fusion, Inc.(BMEA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Biomea Fusion, Inc.,BMEA,Biomea Fusion, Inc.股票,Biomea Fusion, Inc.股票老虎,Biomea Fusion, Inc.股票老虎国际,Biomea Fusion, Inc.行情,Biomea Fusion, Inc.股票行情,Biomea Fusion, Inc.股价,Biomea Fusion, Inc.股市,Biomea Fusion, Inc.股票价格,Biomea Fusion, Inc.股票交易,Biomea Fusion, Inc.股票购买,Biomea Fusion, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biomea Fusion, Inc.(BMEA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Biomea Fusion, Inc.(BMEA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}